Other studies have confirmed more objective immunohistochemical evaluation of cellular proliferation as correlating with an overall worse outcome using Ki 67 analysis, [2] proliferating cell nuclear antigen labelling index, cellular apoptotic marker (Bcl-2 and Bax) expression and overall tumour cellularity estimates [12,33,34]. This evidence concerns the gene BCL2 and neoplasm.